𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Posaconazole prophylaxis in patients with acute myelogenous leukaemia – results from an observational study

✍ Scribed by G. Egerer; M. J. P. Geist

Book ID
108916959
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
121 KB
Volume
54
Category
Article
ISSN
0933-7407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy adapted to molecular response in
Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study
✍ Frank Neumann; Judith Markett; Roland Fenk; Monika Pooten; Anne Koch; Daniela Br 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract This study evaluates response‐adapted treatment of chronic myelogenous leukaemia (CML) in chronic phase using molecular response criteria. __bcr‐abl__/G6PDH ratios were assessed by Light‐Cycler quantitative real‐time polymerase chain reaction (PCR( in 277 peripheral blood samples from 3

Pegfilgrastim primary prophylaxis in pat
Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: results from an integrated analysis
✍ R Pettengell; M Schwenkglenks; P Bacon; S Lawrinson; U Duehrsen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

## Abstract Severe neutropenia and febrile neutropenia (FN) are serious, dose‐limiting side effects of chemotherapy for aggressive non‐Hodgkin lymphoma (NHL). Observational data suggest that with current practice neutropenia management up to 23% of patients receiving CHOP‐like regimens experience F